Regorafenib attenuates IFN-γ-induced PD-L1 expression and enhances antitumor immunity

被引：0
|
作者：
Zhu, Xiao-Feng [1 ]
机构：
[1] Sun Yat Sen Univ, Ctr Canc, Guangzhou, Guangdong, Peoples R China
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-2751
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2751
引用
收藏
页数：1
相关论文
共 50 条
  • [31] ß3-adrenergic receptor sustains IFN-γ-dependent PD-L1 expression and impairs anti-tumor immunity in neuroblastoma
    Bruno, Gennaro
    Nastasi, Nicoletta
    Subbiani, Angela
    Boaretto, Alessia
    Tondo, Annalisa
    Favre, Claudio
    Calvani, Maura
    CANCER RESEARCH, 2022, 82 (12)
  • [32] Radiation resistance induced immunity evasion by evoking PD-L1 expression
    Gong, X.
    Li, X.
    Zhou, C.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S89 - S90
  • [33] Radiation resistance induced immunity evasion by evoking PD-L1 expression
    Gong, X.
    Zhou, C.
    Li, X.
    Zhao, C.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S955 - S955
  • [34] The complex role of PD-L1 in antitumor immunity: a recent update
    Xiaoqing Zhang
    Yue Huang
    Xuanming Yang
    Cellular & Molecular Immunology, 2021, 18 : 2067 - 2068
  • [35] Pomalidomide Inhibits PD-L1 Induction to Promote Antitumor Immunity
    Fujiwara, Yuki
    Sun, Yi
    Torphy, Robert J.
    He, Jiadai
    Yanaga, Katsuhiko
    Edil, Barish H.
    Schulick, Richard D.
    Zhu, Yuwen
    CANCER RESEARCH, 2018, 78 (23) : 6655 - 6665
  • [36] Enhanced expression of PD-L1 and IFN-γ on dendritic cells is associated with BCG-induced Th2 inhibition
    Gouveia, A. C. C.
    Braga, F. G.
    Mota, M.
    Silva, F. M. C.
    Brugiolo, A. S. S.
    Oliveira, E. E.
    Ayupe, M. C.
    Teixeira, H. C.
    Ferreira, A. P.
    CYTOKINE, 2017, 99 : 163 - 172
  • [37] Metformin Suppresses Both PD-L1 Expression in Cancer Cells and Cancer-Induced PD-1 Expression in Immune Cells to Promote Antitumor Immunity
    Park, Su Hwan
    Lee, Juheon
    Yun, Hye Jin
    Kim, Seok-Ho
    Lee, Jong-Ho
    ANNALS OF LABORATORY MEDICINE, 2024, 44 (05) : 426 - 436
  • [38] Programmed death ligand 1 (PD-L1) plays a vital part in DC tolerogenicity induced by IFN-γ
    Svajger, Urban
    Tesic, Natasa
    Rozman, Primoz
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 99
  • [39] Dual Faces of IFNγ in Cancer Progression: A Role of PD-L1 Induction in the Determination of Pro- and Antitumor Immunity
    Mandai, Masaki
    Hamanishi, Junzo
    Abiko, Kaoru
    Matsumura, Noriomi
    Baba, Tsukasa
    Konishi, Ikuo
    CLINICAL CANCER RESEARCH, 2016, 22 (10) : 2329 - 2334
  • [40] Abrogation of IFN-γ Signaling May not Worsen Sensitivity to PD-1/PD-L1 Blockade
    Vackova, Julie
    Piatakova, Adrianna
    Polakova, Ingrid
    Smahel, Michal
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (05)
12345